Cargando…
miR-34a mimic or pre-mir-34a, which is the better option for cancer therapy? KatoIII as a model to study miRNA action in human gastric cancer cells
BACKGROUND: Aberrantly expressed microRNAs play important roles in gastric tumorigenesis. However, use of miRNAs as a therapeutic option in gastric cancer still remains as a challenging problem. METHODS: We performed transient transfection of miR-34a-5p mimic and stable transfection of pre-mir-34a i...
Autores principales: | Jafari, Narjes, Abediankenari, Saeid, Hossein-Nataj, Hadi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980621/ https://www.ncbi.nlm.nih.gov/pubmed/33740991 http://dx.doi.org/10.1186/s12935-021-01872-5 |
Ejemplares similares
-
MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer
por: Chen, Ai-Hua, et al.
Publicado: (2017) -
Expression patterns of seven key genes, including β-catenin, Notch1, GATA6, CDX2, miR-34a, miR-181a and miR-93 in gastric cancer
por: Jafari, Narjes, et al.
Publicado: (2020) -
Downregulation of tumor‐derived exosomal miR-34c induces cancer‐associated fibroblast activation to promote cholangiocarcinoma progress
por: Qin, Xinglei, et al.
Publicado: (2021) -
UTMD promoted local delivery of miR-34a-mimic for ovarian cancer therapy
por: Li, Yue, et al.
Publicado: (2021) -
Analysis of the miR-34 family functions in breast cancer reveals annotation error of miR-34b
por: Engkvist, M. E., et al.
Publicado: (2017)